Agent for treating disease due to constrictive vascular lesion

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/166 (2006.01) A61P 9/08 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2404775

Preventive and/or therapeutic drugs for diseases due to stenotic lesions of blood vessel, which contain as the active ingredient hydroxamic acid derivatives of the general formula (I) exhibiting matrix metalloprotease inhibiting activity or nontoxic salts thereof: wherein R1 is hydrogen, C1-8 alkyl, or C1-8 alkyl substituted with OR2, R2 being hydrogen, C1-8 alkyl, benzyl, or C1-8 alkyl substituted with C1-8 alkoxy.

L'invention concerne des médicaments préventifs et/ou thérapeutiques pour le traitement de maladies associées aux lésions sténosées de vaisseaux sanguins. Lesdits médicaments contiennent comme principe actif des dérivés d'acide hydroxamique de formule générale (I), présentant une activité inhibitrice de métalloprotéase matricielle, ou des sels non toxiques desdits dérivés. Dans ladite formule, R?1¿ représente hydrogène, C¿1-8 ?alkyle ou C¿1-8 ?alkyle substitué par OR?2¿, R?2¿ représentant hydrogène, C¿1-8 ?alkyle, benzyle ou C¿1-8 ?alkyle substitué par C¿1-8? alcoxyle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Agent for treating disease due to constrictive vascular lesion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for treating disease due to constrictive vascular lesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treating disease due to constrictive vascular lesion will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1981553

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.